Detailed Information
Cited 4 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting: DOMENICA study (GINECO-EN105b/ENGOT-en13 study)
- Authors
- Joly, F[Joly, Florence]; Ray-Coquard, IL[Ray-Coquard, Isabelle Laure]; Rubio, MJ[Rubio, Maria Jesus]; Paoletti, X[Paoletti, Xavier]; Davis, AJ[Davis, Alison J.]; Hudson, E[Hudson, Emma]; Lorusso, D[Lorusso, Domenica]; Tognon, G[Tognon, Germana]; Hasler-Strub, U[Hasler-Strub, Ursula]; Choi, CH[Choi, Chel Hun]; Vardar, MA[Vardar, Mehmet Ali]; Lheureux, S[Lheureux, Stephanie]; Van Gorp, T[Van Gorp, Toon]; Tan, DSP[Tan, David Shao Peng]; Trillsch, F[Trillsch, Fabian]; Eberst, L[Eberst, Lauriane]; Lescure, C[Lescure, Celine]; Hardy-Bessard, AC[Hardy-Bessard, Anne-Claire]; Chaix, M[Chaix, Marie]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.